Replies to post #82120 on Innovation Pharmaceuticals Inc (IPIX)

[daydreaming2]

Guess who is in charge of NASDAQ.... That's right NASDAQ. Cellceutix would not be the first or last to receive a waiver on any part of the requirements based on other information that gives NASDAQ the warm and fuzzy... But hey up list in 2 or 3 months... whatever I am not selling anytime soon so I can wait for the big boys to be let in!

GLTA

[thefamilyman]

The part you put in bold refers to the NASDAQ National Market. Look further down the page at the NASDAQ SmallCap Market.

[TheHound]

We've covered this topic at least a hundred times on this forum. Where have you been?

[TOB]

CTIX is 5 days into the the 90 day $4 bid price requirement for the Market Value Standard for NASDAQ Global Market. No Total Assets or Total Revenue required under that standard.

They would need to add Directors.

Interestingly, they have added NASDAQ Capital Market. This allows a closing price alternative of $2. They don't specify a period, but CTIX has closed above $2 for 90 days.

The Capital Market is a competitor to the NYSE MKT/Amex, which I believe CTIX also qualifies for. But the CEO appears to be targeting NASDAQ, possibly Global Market.

This is a better guide than the one you linked to, it is directly from NASDAQ:

https://listingcenter.nasdaqomx.com/assets/initialguide.pdf

The CEO indicated in an email that he saw 1 year's operating capital as a requirement. If so, a higher share price or partnership for Brilacidin P3 may need to occur first.

So March 2015 looks like a possibility if the share price holds or increases. Or sooner if the Capital Market is chosen.